High-pressure liquid chromatographic assay for hydralazine in human plasma

T. M. Ludden, L. K. Goggin, J. L. McNay, K. D. Haegele, Alexander M Shepherd

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

A specific high-performance liquid chromatographic assay for hydralazine in human plasma was developed. Plasma hydralazine is reacted with 10 μl of p-anisaldehyde for 7 min at room temperature to form hydrazaline p-anisaldehyde hydrazone. This derivative is extracted into ethyl acetate, and the solvent is removed by evaporation. The residue is reconstituted in 100 μl of methanol, and 90 μl is injected onto a reversed-phase column. The mobile phase is 32% acetonitrile in 0.75 M acetate buffer, pH 3.4, at a flow rate of 2 ml/min. The retention time of hydralazine p-anisaldehyde hydrazone is 6.5 min. The average coefficient of variation over 10-200 ng/ml is 5.5%, and the sensitivity limit is 5 ng/ml. Under the assay conditions, hydralazine pyruvic acid hydrazone, a known plasma metabolite of hydralazine, yields <0.1% hydralazine. Detectable plasma hydralazine levels of 5-20 ng/ml were found 10-30 min after a 0.5-mg/kg oral dose of hydralazine hydrochloride was given to a male volunteer.

Original languageEnglish (US)
Pages (from-to)1423-1425
Number of pages3
JournalJournal of Pharmaceutical Sciences
Volume68
Issue number11
DOIs
StatePublished - 1979

Fingerprint

Plasma (human)
Hydralazine
Assays
Pressure
Liquids
Hydrazones
Plasmas
Metabolites
Methanol
Volunteers
Buffers
Evaporation
Acetates
Flow rate
Derivatives
Temperature

ASJC Scopus subject areas

  • Drug Discovery
  • Organic Chemistry
  • Chemistry(all)
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science

Cite this

Ludden, T. M., Goggin, L. K., McNay, J. L., Haegele, K. D., & Shepherd, A. M. (1979). High-pressure liquid chromatographic assay for hydralazine in human plasma. Journal of Pharmaceutical Sciences, 68(11), 1423-1425. https://doi.org/10.1002/jps.2600681123

High-pressure liquid chromatographic assay for hydralazine in human plasma. / Ludden, T. M.; Goggin, L. K.; McNay, J. L.; Haegele, K. D.; Shepherd, Alexander M.

In: Journal of Pharmaceutical Sciences, Vol. 68, No. 11, 1979, p. 1423-1425.

Research output: Contribution to journalArticle

Ludden, TM, Goggin, LK, McNay, JL, Haegele, KD & Shepherd, AM 1979, 'High-pressure liquid chromatographic assay for hydralazine in human plasma', Journal of Pharmaceutical Sciences, vol. 68, no. 11, pp. 1423-1425. https://doi.org/10.1002/jps.2600681123
Ludden, T. M. ; Goggin, L. K. ; McNay, J. L. ; Haegele, K. D. ; Shepherd, Alexander M. / High-pressure liquid chromatographic assay for hydralazine in human plasma. In: Journal of Pharmaceutical Sciences. 1979 ; Vol. 68, No. 11. pp. 1423-1425.
@article{01276df427d340f6a0693a65ad70de63,
title = "High-pressure liquid chromatographic assay for hydralazine in human plasma",
abstract = "A specific high-performance liquid chromatographic assay for hydralazine in human plasma was developed. Plasma hydralazine is reacted with 10 μl of p-anisaldehyde for 7 min at room temperature to form hydrazaline p-anisaldehyde hydrazone. This derivative is extracted into ethyl acetate, and the solvent is removed by evaporation. The residue is reconstituted in 100 μl of methanol, and 90 μl is injected onto a reversed-phase column. The mobile phase is 32{\%} acetonitrile in 0.75 M acetate buffer, pH 3.4, at a flow rate of 2 ml/min. The retention time of hydralazine p-anisaldehyde hydrazone is 6.5 min. The average coefficient of variation over 10-200 ng/ml is 5.5{\%}, and the sensitivity limit is 5 ng/ml. Under the assay conditions, hydralazine pyruvic acid hydrazone, a known plasma metabolite of hydralazine, yields <0.1{\%} hydralazine. Detectable plasma hydralazine levels of 5-20 ng/ml were found 10-30 min after a 0.5-mg/kg oral dose of hydralazine hydrochloride was given to a male volunteer.",
author = "Ludden, {T. M.} and Goggin, {L. K.} and McNay, {J. L.} and Haegele, {K. D.} and Shepherd, {Alexander M}",
year = "1979",
doi = "10.1002/jps.2600681123",
language = "English (US)",
volume = "68",
pages = "1423--1425",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "11",

}

TY - JOUR

T1 - High-pressure liquid chromatographic assay for hydralazine in human plasma

AU - Ludden, T. M.

AU - Goggin, L. K.

AU - McNay, J. L.

AU - Haegele, K. D.

AU - Shepherd, Alexander M

PY - 1979

Y1 - 1979

N2 - A specific high-performance liquid chromatographic assay for hydralazine in human plasma was developed. Plasma hydralazine is reacted with 10 μl of p-anisaldehyde for 7 min at room temperature to form hydrazaline p-anisaldehyde hydrazone. This derivative is extracted into ethyl acetate, and the solvent is removed by evaporation. The residue is reconstituted in 100 μl of methanol, and 90 μl is injected onto a reversed-phase column. The mobile phase is 32% acetonitrile in 0.75 M acetate buffer, pH 3.4, at a flow rate of 2 ml/min. The retention time of hydralazine p-anisaldehyde hydrazone is 6.5 min. The average coefficient of variation over 10-200 ng/ml is 5.5%, and the sensitivity limit is 5 ng/ml. Under the assay conditions, hydralazine pyruvic acid hydrazone, a known plasma metabolite of hydralazine, yields <0.1% hydralazine. Detectable plasma hydralazine levels of 5-20 ng/ml were found 10-30 min after a 0.5-mg/kg oral dose of hydralazine hydrochloride was given to a male volunteer.

AB - A specific high-performance liquid chromatographic assay for hydralazine in human plasma was developed. Plasma hydralazine is reacted with 10 μl of p-anisaldehyde for 7 min at room temperature to form hydrazaline p-anisaldehyde hydrazone. This derivative is extracted into ethyl acetate, and the solvent is removed by evaporation. The residue is reconstituted in 100 μl of methanol, and 90 μl is injected onto a reversed-phase column. The mobile phase is 32% acetonitrile in 0.75 M acetate buffer, pH 3.4, at a flow rate of 2 ml/min. The retention time of hydralazine p-anisaldehyde hydrazone is 6.5 min. The average coefficient of variation over 10-200 ng/ml is 5.5%, and the sensitivity limit is 5 ng/ml. Under the assay conditions, hydralazine pyruvic acid hydrazone, a known plasma metabolite of hydralazine, yields <0.1% hydralazine. Detectable plasma hydralazine levels of 5-20 ng/ml were found 10-30 min after a 0.5-mg/kg oral dose of hydralazine hydrochloride was given to a male volunteer.

UR - http://www.scopus.com/inward/record.url?scp=0018728335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018728335&partnerID=8YFLogxK

U2 - 10.1002/jps.2600681123

DO - 10.1002/jps.2600681123

M3 - Article

C2 - 512893

AN - SCOPUS:0018728335

VL - 68

SP - 1423

EP - 1425

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 11

ER -